secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0000950170-25-078439
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics annual meeting results: all director nominees elected, say-on-pay approved
--------------------------------------------------------------------------------

- All five director nominees elected; Frank Morich received 35.4M for and 17.1M withheld (33% withhold).
- Say-on-pay passed with 73.7% support (38.7M for, 13.7M against, 0.15M abstain), excluding 8.3M broker non-votes.
- Ratification of WithumSmith+Brown as auditor approved with 59.1M for, 1.6M against, 0.14M abstain.
- Quorum of 82.17% of 74,050,841 shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000095017025078439/0000950170-25-078439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000095017025078439/catx-20250528.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-078439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer